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Purpose: Older African Americans experience disproportionately higher incidence of morbidity 
and mortality related to chronic and infectious diseases, yet are significantly underrepresented 
in clinical research compared to other racial and ethnic groups. This study aimed to understand 
the extent to which social support, transportation access, and physical impediments function as 
barriers or facilitators to clinical trial recruitment of older African Americans.
Methods: Participants (N=221) were recruited from six African American churches in Atlanta 
and surveyed on various influences on clinical trial participation.
Results: Logistic regression models demonstrated that greater transportation mobility (odds 
ratio [OR]=2.10; p=0.007) and social ability (OR=1.77; p=0.02) were associated with increased 
intentions of joining a clinical trial, as was greater basic daily living ability (OR=3.25; p=0.03), 
though only among single participants. Among adults age ≥65 years, those with lower levels 
of support during personal crises were more likely to join clinical trials (OR=0.57; p=0.04).
Conclusion: To facilitate clinical trial entry, recruitment efforts need to consider the physical 
limitations of their potential participants, particularly basic physical abilities and disabilities. 
Crisis support measures may be acting as a proxy for personal health issues among those aged 
>65 years, who would then be more likely to seek clinical trials for the personal health benefits. 
Outreach to assisted living homes, hospitals, and other communities is a promising avenue for 
improved clinical trial recruitment of older African Americans.
Keywords: clinical trials, aging, minority populations, African Americans, physical disabilities
Introduction
Older Black/African American adults have been underrepresented in clinical trials com-
pared to their Caucasian peers.1–4 Enrollment disparity has been so widely recognized 
that the US National Institutes of Health (NIH) released broader guidelines in 1994 to 
address the historical problem of under enrollment of racial and ethnic minorities and 
women.5 Disparate rates of participation are problematic, as clinical trial findings become 
difficult to generalize; indeed, medications, devices, interventions, and treatments may 
not be indicated for specific demographic groups based upon findings derived from 
populations lacking diversity.1 Recent reviews of participant recruitment and enroll-
ment in cancer, heart failure, surgical oncology, and lung injury trials reflect racial- and 
gender-based enrollment disparities that have resulted in reduced generalizability.6–9
The factors contributing to clinical trial motivation among diverse populations 
include perceived participation advantages ranging from special access to health 
care and premarket treatments to a broader sense of purpose (altruism).10,11 Yet, most 
of the prior research on clinical trial participation among African Americans has 
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highlighted potential participants’ psychosocial challenges, 
such as distrust of researchers, unexpected costs, and lack of 
familiarity with clinical studies.12–14 More recently, however, 
attention has been given to factors facilitating access to care 
and the health and well-being of older adults such as mobil-
ity, social participation, and neighborhood characteristics 
such as availability of trials in the residential area.15,16 These 
factors have demonstrated an influence on health decision 
making among older Black/African American individuals 
(e.g., vaccination).17,18
A call to action has been issued for novel strategies to 
improve clinical trials participation rates among older African 
Americans, who experience greater morbidity and mortality 
for many infectious and chronic diseases (e.g., HIV, colorec-
tal cancer, diabetes, hypertension), which could be reduced 
through new medical advances.1,19–24 Accounting for physical 
disability and functional impairments typical of older persons 
is therefore critical to the assessment of a broader scope of 
socioenvironmental factors that may be important determi-
nants in realizing greater diversity in future clinical trials.25
This study examines other factors that may influence 
enrollment decision making among this highly vulnerable 
group, including personal, social, and community barriers 
and facilitators. This study assesses considerations associ-
ated with clinical research participation drawing upon the 
socioecological framework for human behavior.26 Thus, we 
examined the interaction between individual-level factors 
(sociodemographics, physical abilities such as strength and 
mobility, social abilities, errand transportation availability, 
and other independent assessments of functional abilities), 
interpersonal-level factors (social support and crisis support), 
and community-level factors (transportation access).
Methods
Study procedures
Study design and sample
The data were collected from a cohort of 221 African Ameri-
cans recruited in metropolitan Atlanta, Georgia through a 
cluster randomized controlled trial design.26 In conjunction 
with this analyses, we also evaluated the feasibility and 
potential effectiveness of the “Dose of Hope” intervention 
to test whether delivery of a three-session group intervention 
increased the proportion of older African Americans who 
enrolled in an array of chronic and infectious disease-related 
clinical trials.27 Our inclusion criteria included those who 
self-reported being primarily Black/African American, ≥50 
years of age, a congregant of one of the six African Ameri-
can participating churches, and having no previous history 
of clinical research participation. All participants provided 
written informed consent.
Data collection
We conducted surveys with all enrolled participants at base-
line and 3-month time points between January 2013 and May 
2014. The surveys measured various influences on clinical 
trial participation, designed using established macro- and 
micro-theoretical models, including the socioecological 
model and an extended theory of reasoned action.28–33 As 
such, the measures include those pertaining to nested influ-
ences from the community- to individual-level, as well as 
moderating and mediating influences on attitudes and social 
norms toward trial participation.24–26 Items analyzed from this 
study included linked data from the baseline and 3-month 
questionnaires containing sociodemographic questions (i.e., 
age, gender, education level, income, and relationship status) 
as well as functional disability and social support scales.34,35
The primary outcome was the self-reported intention 
that individuals would participate in clinical research. It was 
measured through a single item on the baseline survey, “On 
a scale from 0 (definitely not) to 10 (definitely so), rank your 
likelihood of joining a medical research study within the next 
6 months.” For this analysis, we dichotomized responses 
using a median split, with responses of 6 or below categorized 
as less likely to join a study and those 7 or higher categorized 
as likely to join a clinical study.
Ethical considerations
The project was reviewed and approved by the Institutional 
Review Board of Emory University (IRB 00057210).
Physical and social ability measures
Participant’s physical abilities (“Functional Ability”) and 
available social support (“Social Support”) were measured 
using multi-item survey instruments. Functional Ability was 
assessed through 15 items measuring ability in daily living 
and 4 questions measuring long-term physical abilities, 
developed from the “Functional Status Questionnaire.”34 
Social Support consisted of a 19-item validated instrument 
on medical outcomes and social support.35
Social Support and Functional Ability scales were trans-
formed into factor scores for analysis. An expected maximum 
imputation was used to impute missing items using other 
components of the same scale when >50% of the scale items 
were completed. For each instrument, principal component 
extraction was performed followed by varimax rotation. 
Significant factor loadings were identified as loadings over 
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0.5, and crossloading items were removed. Only two items 
were removed, both from the Social Support scale: “How 
often do you have someone to take you to the doctor if you 
needed it?” and “How often do you have someone to confide 
in or talk to about yourself or your problems?” The number 
of factors was selected for both an eigenvalue over 1.0 and 
interpretability.
Factor internal reliability was assessed with Cronbach’s 
alpha, with an alpha >0.70 considered acceptably reliable. 
All resulting factors from the Functional Ability and Social 
Support scales had alpha >0.75. The four items measuring 
long-term physical abilities were analyzed via factor analysis 
but had poor internal consistency, with alpha <0.70. Finally, 
standardized factor scores were computed using the regres-
sion method.
The Functional Ability scale scores resulted in four sub-
scales: “Basic Ability”, “Strength and Mobility”, “Social 
Ability”, and “Errand Transportation”. Basic Ability 
measures the participant’s independence in basic daily life 
activities, such as dressing, feeding, or bathing themselves. 
Strength and Mobility measures instrumental daily life 
activities requiring more functional ability, such as chores, 
walking outside the home, and using public transportation. 
Social Ability measures functional ability necessary to sup-
port social activities, such as the ability to participate in 
community activities or visit others. Errand Transportation 
measures independence in transportation, like the ability to 
drive and do errands such as shopping.
The larger Social Support scale resulted in two subscales: 
“Social Support” and “Crisis Support”. Social Support mea-
sures the availability of social support in day-to-day life, such 
as the availability of others who give advice, show love and 
affection, or who are available for recreation. Crisis Support 
measures available support from others in the case of crisis 
or loss of functional ability, such as help when confined to a 
bed or availability of someone to talk to about a crisis.
Analysis
All analyses were completed using Statistical Package for the 
Social Sciences (SPSS) version 22 (SPSS, Inc., Chicago, IL, 
USA). Descriptive statistics were obtained for all variables of 
interest. Bivariate odds ratios (ORs) and prevalence ratios (PRs) 
were estimated to explore direct associations between participant 
intention to join clinical research and sociodemographic factors, 
Functional Ability measures, and Social Support measures. 
Bivariate ORs and 95% confidence intervals were estimated 
using bivariate logistic regression, and bivariate PRs and confi-
dence intervals estimated by bivariate log binomial regression. 
A logistic regression model was fit to assess the individual and 
cumulative associations with the dichotomized outcome. A 
Poisson regression using robust covariance estimates was also 
fit to estimate adjusted PRs. The robust Poisson model was 
chosen over the log-binomial model to facilitate convergence 
of estimates.
Of the 221 persons enrolled in the study, 7 participants 
did not complete the outcome item at baseline (3% missing), 
3 were missing age information (1.4% missing), and 23 were 
missing factor scores for either the Functional Ability or 
Social Support scales (10.4%); the resulting analysis included 
191 complete cases (13.6% overall). The multivariable mod-
els included two-way interactions between factor scores and 
demographic variables (age, gender, income, education, and 
relationship status). Collinearity between independent fac-
tors within each model was assessed using variance inflation 
factors (VIFs).
Results
Participant and sample characteristics
At baseline, 221 participants completed the survey, while 
211 completed the 3-month survey. The mean age was 63.6 
years (standard deviation [SD]=7.50), though ages ranged 
from 50 to 90 (Table 1). There were 173 females (78.3%) 
and 48 males (21.7%). The majority of participants had an 
associate’s degree or higher (n=142, 64.3%). There was a 
moderate spread of household income, with the plurality 
claiming an income below $20,000 (n=61, 27.6%) and fewest 
claiming a household income over $100,001 (n=13, 5.9%). 
Participant employment varied, with the fewest claiming 
part-time employment (n=18, 8.1%) and the most respond-
ing that they were retired (n=85, 38.5%). Participants were 
primarily married (n=102, 46.2%) or separated/divorced 
(n=59, 26.7%). Table 1 also displays the sociodemographic 
characteristics of the 191 participants for whom we could 
include in the multivariable logistic regression model as they 
had complete case data (labeled “complete cases”).
The outcome variable, likelihood of joining a clinical 
study at baseline, had a mean score of 5.83 (n=214, SD=2.68) 
and a median score of 6 (0=definitely not, 10=definitely so). 
The most frequently selected score was a 5 with 42 responses 
and 19.0% of all responses.
Functional Ability and Social  
Support scales
The 15 Functional Impairment items resulted in four  factors: 
Basic Ability (5 items, α=0.97), Strength and Mobility 
(5 items, α=0.97), Social Ability (3 items, α=0.97), and 
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Errand Transportation (2 items, α=0.97). The two resulting 
factors for Social Support were Crisis Support (3 items, 
α=0.85) and Social Support (14 items, α=0.97). The four 
long-term ability items resulted in a single factor with 
α=0.698; because the α was not >0.70, these items were 
treated individually for analysis.
Items included in the Functional Ability factor scales 
demonstrated high levels of ability (Table 2). Within Basic 
Ability, average scores ranged from 3.91 to 3.97 (1=no 
 difficulty, 4=too difficult to do). In the factor of Strength and 
Mobility, the 5 items ranged from 3.11 to 3.76, representing 
high levels of strength or low mobility impairment. Within the 
category of Social Ability, scores ranged from 3.72 to 3.84, 
indicating higher levels of social abilities. Errand Transpor-
tation scores averaged 3.92 (SD=0.31) for “…driving a car” 
and 3.84 (SD=0.39) for “…doing errands”, demonstrating 
high ability to complete errands.
The Social Support factors had mean scores ranging 
from 3.87 to 4.30 (1=none of the time, 5=all of the time), 
 indicating high average availability of social support 
Table 1 Sociodemographic characteristics of study participants
Item Total sample (n=221), n (%) Complete casesa (n=191), n (%)
Age, years (missing, n=3)
50–54 23 (10.4) 22 (110.5)
55–59 39 (17.6) 35 (18.3)
60–64 58 (26.2) 50 (26.2)
65–69 50 (22.6) 46 (24.1)
70–79 41 (18.6) 33 (17.3)
≥80 7 (3.2) 5 (2.6)
Gender
Female 173 (78.3) 146 (76.4)
Male 48 (210.7) 45 (23.6)
Race
African American/Black 217 (98.2) 187 (97.9)
Multiracial/multicultural 4 (10.8) 4 (2.1)
Ethnicity (missing, n=45)
Non-Hispanic 175 (79.2) 157 (82.5)
Hispanic/Latino/Chicano 1 (0.5) 1 (0.5)
Highest level of education
Kindergarten–8th grade 3 (10.4) 2 (10.0)
9th–11th grade 10 (4.5) 6 (3.1)
High school graduate/GED 66 (29.9) 60 (310.4)
Technical/vocational/associates 66 (29.9) 55 (28.8)
Bachelor’s degree 37 (16.7) 33 (17.3)
Master’s degree 33 (14.9) 29 (15.2)
Doctorate 6 (2.7) 6 (3.1)
Household income (missing, n=23)
<$20,000 61 (27.6) 50 (26.2)
$20,001–$40,000 49 (22.2) 42 (22.0)
$40,001–$60,000 36 (16.3) 34 (17.8)
$60,001–$80,000 20 (9.0) 18 (9.4)
$80,001–$100,000 19 (8.6) 17 (8.9)
>$100,001 13 (5.9) 13 (6.8)
Employment (missing, n=8)
Employed – full time 43 (19.5) 38 (19.9)
Employed – part time 18 (8.1) 18 (9.4)
Unemployed 37 (16.7) 32 (16.8)
Other (retired, n=85, 44.4%) 115 (52.0) 97 (50.8)
Relationship status
Single/never married 24 (10.9) 20 (10.5)
Married/domestic partner 102 (46.2) 89 (46.6)
Divorced/separated 59 (26.7) 51 (26.7)
Widowed 35 (15.8) 30 (15.7)
Other 1 (0.5) 1 (0.5)
Note: aComplete cases are those participants who have responses for all variables included in the logistic regression model.
Abbreviations: GED, General Education Development high school equivalency diploma.
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(Table 3).  Similarly, items included in the Crisis Support 
factor had means of 3.67–4.03, also indicating moderately 
high levels of crisis support.
Associations with likelihood of joining 
clinical trials
Bivariate analysis
Bivariate ORs and PRs were estimated to explore direct 
associations between participant intentions to join clinical 
trials and sociodemographic factors, Social Support, and 
Functional Ability (Table 4). Those participants with greater 
access to Errand Transportation indicated greater intention 
to participate in clinical research (OR=1.77, 95% CI: [1.09, 
2.86], p=0.02; PR=1.24 [1.00, 1.54], p=0.05). No other statis-
tically significant bivariate associations were found amongst 
the Functional Ability measures, Social Support measures, 
or tested sociodemographic factors.
Multivariable models
Multivariable logistic and robust Poisson models were run to 
assess the relationships between sociodemographics, physical 
ability, social support, and the outcome variable. The final 
model was selected according to potential influences on 
clinical trial participation identified by previous research and 
theory.15,36 We included two interaction terms based on the 
hypotheses that the effect of available Crisis Support would 
be moderated by age and that Basic Ability would be most 
important for single participants. The final model included 
four measures of sociodemographics, the two social support 
factors, the four functional impairment factors, and the two 
interaction terms. The four long-term physical ability items 
were not included due to potential redundancy with the Basic 
Ability factor score. Multicollinearity was assessed using 
VIFs, and all factors were below five so within acceptable 
range.
The final logistic regression model was significant 
(Χ2=22.24, p=0.03) with a Nagelkerke R2 score of 0.15. 
The Hosmer and Lemeshow fit test was nonsignificant 
(Χ2=5.97, p=0.6), indicating a lack of evidence for poor 
fit. The statistically significant factors were very similar 
between the multivariable logistic and robust Poisson mod-
els. Two independent variables were significantly related to 
likelihood to join a clinical study: greater intentions to join 
clinical trials were associated with greater Social Ability 
(OR=1.77, 95% CI: [1.09, 2.87], p=0.02; PR=1.42 [1.09, 
1.86], p=0.009) and greater access to Errand Transporta-
tion (OR=2.09 [1.22, 3.57], p=0.007; PR=1.57 [1.14, 2.19], 
p=0.008) (Table 5).
Two more variables were significantly associated with 
the likelihood to join clinical trials for certain values of a 
moderating factor. Greater intention to join clinical trials 
was associated with greater Basic Ability, but only among 
single participants (OR=3.25 [1.16, 9.10], p=0.03; PR=2.08 
[1.24, 3.48], p=0.005). Crisis Support was not significantly 
Table 2 Functional ability scale: resultant factors and factor loadings
Factor “In the past month, have you had difficulty with…” Meana SD Min Max Factor loading
Basic Ability (a=0.879, 5 items)
Feeding yourself? 3.97 0.21 2 4 0.78
Dressing yourself? 3.95 0.25 2 4 0.90
Moving in and out of bed? 3.91 0.31 2 4 0.76
Bathing yourself? 3.95 0.23 2 4 0.90
Walking around your home? 3.91 0.29 2 4 0.59
Strength and Mobility (a=0.861, 5 items)
Walking several blocks? 3.58 0.75 1 4 0.80
Doing house chores such as cleaning? 3.76 0.53 1 4 0.62
Using public transportation? 3.72 0.69 1 4 0.61
Lifting heavy objects? 3.18 0.92 1 4 0.82
Doing physical activity such as running? 3.11 10.05 1 4 0.85
Social Ability (a=0.803, 3 items)
Visiting other peoples’ homes? 3.80 0.50 1 4 0.80
Participating in community activities, such as religious services, social activities,  
or volunteer work?
3.84 0.44 1 4 0.82
Taking care of other people such as family members? 3.72 0.64 1 4 0.53
Errand Transportation (a=0.752, 2 items)
Doing errands, such as grocery shopping? 3.84 0.39 2 4 0.63
Driving a car? 3.92 0.31 2 4 0.88
Notes: a1= Too difficult to do; 4= no difficulty; to aid interpretation, this scale has been reverse-coded from the original survey instrument.
Abbreviations: Max, maximum; Min, minimum; SD, standard deviation.
 
O
pe
n 
Ac
ce
ss
 J
ou
rn
al
 o
f C
lin
ica
l T
ria
ls 
do
wn
lo
ad
ed
 fr
om
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
13
1.
21
6.
16
4.
14
7 
on
 1
6-
M
ay
-2
01
9
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Open Access Journal of Clinical Trials 2017:9submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
26
Shapiro et al
 associated with enrollment intention among participants 
under age 65 years (OR=1.21 [0.76, 1.93], p=0.4; PR=1.13 
[0.86, 1.48], p=0.4). However, for those over 65 years, 
participants with greater Crisis Support were less likely to 
express intentions to join clinical trials (OR=0.57 [0.34, 
0.98], p=0.04; PR=0.81 [0.68, 0.96], p=0.02). The interac-
tion between Crisis Support and age was significant in both 
models (OR=0.47 [0.23, 0.95], p=0.04; PR=0.71 [0.52, 
0.99], p=0.04); however, the interaction between relationship 
status and Basic Ability was only statistically significant in 
the robust Poisson model (OR=0.25 [0.06, 1.09], p=0.07; 
PR=0.44 [0.23, 0.86], p=0.02).
Discussion
Recent reviews of the impact of the NIH Revitalization Act on 
clinical trial participation reflect an ongoing need for greater 
numbers of African Americans in clinical studies.22 This study 
offered confirmation that socioecological factors, extending 
beyond psychosocial considerations, were predictive of enroll-
ment in clinical trials among an older population of African 
Americans. Social support, high functioning, and mobility 
facilitate greater participation in clinical trials in geographic 
areas with trial availability. These findings are consistent with 
others that have identified environmental factors and social 
support as important for achievement of optimal health and 
Table 3 Resultant factors and factor loadings for Social Support scale
Factor (“How often do you have…”) Meana SD Min Max Factor loading
Social Support (a=0.974, 14 items)
Someone who shows you love and affection 4.30 0.87 2 5 0.72
Someone to have a good time with 4.15 0.94 1 5 0.81
Someone to give you information to help you understand a situation 4.12 0.95 1 5 0.73
Someone who hugs you 4.18 10.03 1 5 0.80
Someone to get together with for relaxation 4.04 10.03 1 5 0.88
Someone to prepare you meals if you were unable to do it yourself 3.96 10.17 1 5 0.70
Someone whose advice you really want 4.06 0.96 1 5 0.81
Someone to do things with to help you get your mind off things 4.00 0.99 1 5 0.85
Someone to help with daily chores if you were sick 3.87 10.17 1 5 0.74
Someone to share your most private worries and fears with 4.06 10.04 1 5 0.81
Someone to turn to for suggestions about how to deal with a personal problem 4.07 10.00 1 5 0.79
Someone to do something enjoyable with 4.08 10.01 1 5 0.87
Someone who understands your problems 4.02 10.00 1 5 0.76
Someone to love and make you feel wanted 4.18 10.02 1 5 0.79
Crisis Support (a=0.847, 3 items)
Someone to help you if you were confined to a bed 3.67 10.37 1 5 0.78
Someone you can count on to listen to you when you need to talk 4.03 10.08 1 5 0.81
Someone to give you good advice about a crisis 4.01 10.07 1 5 0.86
Items Removed From Analysis
Someone to take you to the doctor if you needed it 4.11 10.10 1 5 –
Someone to confide in or talk to about yourself or your problems 4.22 0.94 1 5 –
Notes: a1=“None of the time”; 5=“all of the time”.
Abbreviations: Max, maximum; Min, minimum; SD, standard deviation.
Table 4 Bivariate associations with likelihood of joining clinical studies
Factor Odds ratio (95% CI) p-value Prevalence ratio (95% CI) p-value
Age (ref = <65 years) 1.18 (0.68, 2.05) 0.6 1.10 (0.80, 1.52) 0.6
Gender (ref = m) 1.11 (0.58, 2.14) 0.7 1.06 (0.72, 1.58) 0.8
Education (ref = Kindergarten–12) 1.07 (0.60, 1.90) 0.8 1.04 (0.74, 1.46) 0.8
Relationship Status (ref = single) 1.10 (0.64, 1.90) 0.7 1.06 (0.77, 1.45) 0.7
Social Support 0.98 (0.75, 1.29) 0.9 0.99 (0.83, 1.17) 0.9
Crisis Support 0.94 (0.72, 1.24) 0.7 0.97 (0.83, 1.13) 0.7
Basic Ability 1.29 (0.82, 2.02) 0.3 1.12 (089, 1.42) 0.3
Strength and Mobility 1.05 (0.79, 1.41) 0.7 1.03 (0.87, 1.23) 0.7
Social Ability 1.27 (0.88, 1.84) 0.2 1.12 (0.92, 1.36) 0.3
Errand Transportation 1.53 (1.02, 2.28) 0.04* 1.24 (1.00, 1.54) 0.05
Note: *p<0.05.
Abbreviations: CI, confidence interval; m, male; ref, reference.
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well-being among diverse older  populations.15,16,37–39 Our 
findings offer validation of the broader scope of issues that 
may be impacting older African Americans’ willingness to 
participate in clinical trials.
We found that the examined sociodemographic factors 
were not significantly related to likelihood of joining a clini-
cal study when functional impairment and social support were 
taken into account. Gender, age, education, and relationship 
status were not found to be significantly related to future 
enrollment intentions. Previous studies have demonstrated 
disparities among these factors in trial enrollment and in will-
ingness to participate in trials among ill individuals.6,8,36,40,41 
That these factors did not seem to affect willingness to par-
ticipate in clinical trials among our cross-sectional sample 
of older church-going African Americans is an encouraging 
signal for inclusion of diverse older participants in future 
clinical trials. This homogeneity suggests that disparities 
in enrollment and willingness to participate in trials among 
patients do not necessarily reflect disparities in willingness of 
the population. Instead, they may arise from specific barriers 
to willingness of specific sick individuals, or from structural 
issues in trial enrollment that either increase disparity in 
enrollment or differentially affect willingness to participate. 
The findings suggest that ability to get to a clinical trial site 
(personally or through assisted transportation) was due to 
physical challenges, including mobility limitations, an issue 
well described in the literature.42
Most of the predictors of enrollment were related to 
functional impairment. Lower physical functional level, 
and dependency on others to facilitate access to clinics, may 
have greater impact on clinical trial enrollment than other 
 commonly perceived factors such as historical distrust of 
medical research and lack of knowledge about the medical 
field.12–14,43 In turn, the lack of evidence for an association 
between social support and willingness to participate in 
research suggests that barriers may play a larger role in 
clinical trial enrollment than facilitators, a premise not yet 
thoroughly investigated in the literature. Even if individuals 
have adequate support for their enrollment decision (such 
as transportation and emotional support), the inability to get 
dressed in the morning is, understandably, a greater hurdle 
to overcome.
The associations with three of the four functional impair-
ment factors indicate a high association between overall physi-
cal function and the willingness to participate in clinical trials. 
Within the entire sample, the higher ability scores as measured 
by Basic Ability, Social Ability, and Errand Transportation 
significantly predicted higher likelihood of joining a clinical 
study. Lack of availability of transportation to research sites 
has been previously identified as a barrier to trial participa-
tion in both qualitative and quantitative studies as well as our 
own.44 The degree to which logistical issues such as trans-
portation access are barriers will likely be highly dependent 
upon local circumstances and environmental factors; within 
the urban setting of our study, they appear to be a concern.
It is understandable that the barriers associated with 
ability to perform daily tasks would also contribute to the 
decreased likelihood of joining any study. The types of 
physical abilities for these factors include components such 
as basic hygiene like bathing and dressing, getting out into 
the community, and driving and performing errands. These 
are skills that are needed to independently interact with and 
Table 5 Results of multivariable logistic and robust Poisson regression models for factors associated with likelihood of joining clinical 
studies (n=221, missing=30)
Factor Logistic model Robust Poisson model
Odds ratio (95% CI) p-value Prevalence ratio (95% CI) p-value
Agea (ref = <65 years) 1.60 (0.84, 3.05) 0.2 1.24 (0.88, 1.74) 0.2
Gender (ref = m) 1.22 (0.55, 2.68) 0.6 1.11 (0.71, 1.72) 0.6
Education (ref = Kindergarten–12) 0.95 (0.49, 1.85) 0.9 0.98 (0.68, 1.39) 0.9
Relationship Statusb (ref = single) 1.49 (0.72, 3.06) 0.3 1.25 (0.88, 1.78) 0.2
Social Support 0.83 (0.58, 1.17) 0.3 0.91 (0.77, 1.08) 0.3
Crisis Support (age <65 years) 1.21 (0.76, 1.93) 0.4 1.13 (0.86, 1.48) 0.4
Crisis Support (age ≥65 years) 0.57 (0.34, 0.98) 0.04* 0.81 (0.68, 0.96) 0.02*
Basic Ability (for single participants) 3.25 (1.16, 9.10) 0.03* 2.08 (1.24, 3.48) 0.005*
Basic Ability (for participants with a partner) 0.80 (0.32, 2.05) 0.6 0.92 (0.67, 1.27) 0.6
Strength and Mobility 1.11 (0.79, 1.58) 0.5 1.09 (0.87, 1.36) 0.5
Social Ability 1.77 (1.09, 2.87) 0.02* 1.42 (1.09, 1.86) 0.009*
Errand Transportation 2.10 (1.22, 3.60) 0.007* 1.57 (1.13, 2.19) 0.008*
Interaction of Age and Crisis Support 0.47 (0.23, 0.95) 0.04* 0.71 (0.52, 0.99) 0.04*
Interaction of Relationship Status and Basic Ability 0.25 (0.06, 1.09) 0.07 0.44 (0.23, 0.86) 0.02*
Notes: aEffect of age when Crisis Support is 0 (the mean factor score), beffect of Relationship Status when Basic Ability is 0 (the mean factor score), *p<0.05.
Abbreviations: CI, confidence interval; m, male; ref, reference.
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participate in the community15,38,39 as well as participate in a 
clinical trial. Prior research focuses on enrollment exclusions 
related to functional impairment, rather than the logistical 
aspects of participation.41 Our findings suggest that even 
when trials are designed to allow participation by older indi-
viduals with functional impairment, those individuals may 
be less likely to seek out trials when not directly referred. 
Researchers must be willing to logistically facilitate partici-
pation in order encourage participation.
Notably, among those >65 years of age, a lack of crisis 
support was a critically important factor that was predictive 
of intention to participate in trials. Studies with geriatric 
populations have identified crisis support teams as impor-
tant aid for health care decision making, as they account for 
listening to concerns and offering input on dilemmas.45,46 
Thus, having the ability to harness similar decisional sup-
port resources is an important consideration for those who 
may be facing much uncertainty, disability, or comorbidities 
in later life. Additionally, physicians perceive lack of home 
support networks for managing potential treatment side 
effects as a potential barrier to research participation among 
older patients, and as a potential barrier to actually attending 
appointments at which they may be referred or enrolled.41 
However, older individuals lacking crisis support may have 
unique needs due to health issues they are facing, for which 
the crisis support measure may operate as a proxy. The sup-
port they envision receiving from providers and support staff 
conducting clinical trials, and their broader social network 
supporting their enrollment decisions, may therefore be an 
attractive perceived benefit that they associate with participa-
tion in clinical studies.27,30,47,48
Our findings offer important guidance to investigators 
and their clinical research staff on successful recruitment 
strategies for older African Americans. Qualitative inquiry 
may augment these findings to offer important insight on 
social and functional issues encountered by this population 
and how to address these challenges. Foremost among the 
suggestions is to work with nursing or personal care aides 
to reach those who need added assistance with their living 
functions. This may be within residential communities or 
facilities that serve this population. In addition, the items 
related to a support system that includes both someone who 
listens and someone who gives advice hearkens to the strategy 
of partnering with trusted sources of care and community 
members who may have a broad reach among seniors. Thus, 
enlisting pastors and faith leaders in trial participation and 
recruitment might help address the barriers to participation 
among older seniors who are dependent on others for daily 
and crisis support.26,30
Limitations
We recognize the limitations of our study design that employed 
serial cross-sectional behavioral measures of which causality 
may not be directly determined. We also recognize the limi-
tations of self-reported data, as participant, recall, and social 
desirability bias may have been a factor; however, previous 
research with elderly persons has shown that intention, while 
mediated by attitudes, is correlated to actual behavioral out-
comes in both health behavior and volunteerism.49,50 Because 
our sample is drawn from older African Americans attending 
African American churches, our results may not generalize to 
older African Americans who are not church members. How-
ever, we feel that our study encompasses a significant portion 
of this population; a 2009 survey reported that 53% of African 
Americans of all ages attend church on a weekly basis; further, 
64%–65% of African Americans ages ≥50 years are affiliated 
with a historically Black/African American Christian church.51
Conclusion
This study found that previously unexplored factors such as 
physical/environmental and social issues may have on clinical 
trial recruitment potential among older African Americans. 
Our findings illuminate important implications for consid-
eration of logistical issues, such as the role of transportation 
options and social support. In addition, the findings offer 
direction for the pursuit of other nontraditional venues to 
increase participation of those who are homebound or who are 
functionally impaired. Alternative recruitment venues such as 
nursing homes may be necessary to adequately incorporate 
participants who cannot be recruited in traditional settings. 
In addition, studies may need to be best adapted to operate 
in institutions where seniors reside, such as senior living 
facilities or nursing homes, to ensure full participation with 
fewer impediments. 
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